Eubel Brady & Suttman Asset Management Inc Merck & Co., Inc. Transaction History
Eubel Brady & Suttman Asset Management Inc
- $766 Million
- Q3 2024
A detailed history of Eubel Brady & Suttman Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eubel Brady & Suttman Asset Management Inc holds 5,298 shares of MRK stock, worth $510,250. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,298
Previous 5,552
4.57%
Holding current value
$510,250
Previous $687,000
12.37%
% of portfolio
0.08%
Previous 0.1%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,821Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.5 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.3 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.7 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $244B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...